Metabolic profiling of a new synthetic cannabinoid receptor agonist, ADMB-FUBIATA, with human liver microsomes, human primary hepatocytes and human recombinant CYP450 enzymes using LC-quadrupole-orbitrap MS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolic profiling of a new synthetic cannabinoid receptor agonist, ADMB-FUBIATA, with human liver microsomes, human primary hepatocytes and human recombinant CYP450 enzymes using LC-quadrupole-orbitrap MS

Published:2024-10 Issue: Volume:249 Page:116342
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Hou Xiaolong,Zhang Ying,Xu Duoqi,Qin Shiyang,Xue Chenyu,Wang Jifen,Zhou Xinyang,Shangguan Jianyang,Li Zhuoyan,Liu Jiatong,Jia Zhenjun,Lu Jianghai

Publisher

Elsevier BV

Reference34 articles.

1. World drug report 2023. Rep;United Nations Off. Drugs Crime (UNODC),2023

2. From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day;Andrews;Drug Test. Anal.,2023

3. A new cannabinoid receptor 1 selective agonist evading the 2021 "China ban": ADMB-FUBIATA;Deventer;Drug Test. Anal.,2022

4. Diversion Control Division. (2023). National Forensic Laboratory Information System: NFLIS-Drug 2022 annual report. U.S. Department of Justice, U.S. Drug Enforcement Administration.

5. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review;Alves;Crit. Rev. Toxicol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP